vs

Side-by-side financial comparison of Inogen Inc (INGN) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.

SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $68.6M, roughly 1.8× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -4.8%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

INGN vs SWBI — Head-to-Head

Bigger by revenue
SWBI
SWBI
1.8× larger
SWBI
$124.7M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+7.3% gap
INGN
3.4%
-3.9%
SWBI
More free cash flow
SWBI
SWBI
$18.2M more FCF
SWBI
$16.3M
$-1.9M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-4.8%
SWBI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
INGN
INGN
SWBI
SWBI
Revenue
$68.6M
$124.7M
Net Profit
$1.9M
Gross Margin
51.4%
24.3%
Operating Margin
-13.6%
3.3%
Net Margin
1.5%
Revenue YoY
3.4%
-3.9%
Net Profit YoY
-53.6%
EPS (diluted)
$-0.26
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
SWBI
SWBI
Q4 25
$68.6M
$124.7M
Q3 25
$79.1M
$85.1M
Q2 25
$79.2M
$140.8M
Q1 25
$68.5M
$115.9M
Q4 24
$66.3M
$129.7M
Q3 24
$74.9M
$88.3M
Q2 24
$74.4M
$159.1M
Q1 24
$63.1M
$137.5M
Net Profit
INGN
INGN
SWBI
SWBI
Q4 25
$1.9M
Q3 25
$-5.3M
$-3.4M
Q2 25
$-4.2M
$8.6M
Q1 25
$-6.2M
$2.1M
Q4 24
$4.5M
Q3 24
$-6.0M
$-1.9M
Q2 24
$-5.6M
$27.9M
Q1 24
$-14.6M
$7.9M
Gross Margin
INGN
INGN
SWBI
SWBI
Q4 25
51.4%
24.3%
Q3 25
52.2%
25.9%
Q2 25
52.2%
28.8%
Q1 25
53.1%
24.1%
Q4 24
54.7%
26.6%
Q3 24
55.2%
27.4%
Q2 24
57.4%
35.5%
Q1 24
54.5%
28.7%
Operating Margin
INGN
INGN
SWBI
SWBI
Q4 25
-13.6%
3.3%
Q3 25
-9.0%
-3.5%
Q2 25
-7.7%
9.3%
Q1 25
-11.2%
4.1%
Q4 24
-17.2%
5.8%
Q3 24
-10.4%
-1.7%
Q2 24
-9.5%
17.4%
Q1 24
-25.8%
8.2%
Net Margin
INGN
INGN
SWBI
SWBI
Q4 25
1.5%
Q3 25
-6.7%
-4.0%
Q2 25
-5.2%
6.1%
Q1 25
-9.0%
1.8%
Q4 24
3.5%
Q3 24
-8.0%
-2.1%
Q2 24
-7.5%
17.5%
Q1 24
-23.1%
5.7%
EPS (diluted)
INGN
INGN
SWBI
SWBI
Q4 25
$-0.26
$0.04
Q3 25
$-0.20
$-0.08
Q2 25
$-0.15
$0.19
Q1 25
$-0.25
$0.05
Q4 24
$-0.41
$0.10
Q3 24
$-0.25
$-0.04
Q2 24
$-0.24
$0.60
Q1 24
$-0.62
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
SWBI
SWBI
Cash + ST InvestmentsLiquidity on hand
$103.7M
$22.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$363.2M
Total Assets
$298.6M
$548.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
SWBI
SWBI
Q4 25
$103.7M
$22.4M
Q3 25
$106.5M
$18.0M
Q2 25
$103.7M
$25.2M
Q1 25
$118.9M
$26.7M
Q4 24
$113.8M
$39.1M
Q3 24
$105.7M
$35.5M
Q2 24
$97.9M
$60.8M
Q1 24
$107.4M
$47.4M
Stockholders' Equity
INGN
INGN
SWBI
SWBI
Q4 25
$192.2M
$363.2M
Q3 25
$197.2M
$364.4M
Q2 25
$199.5M
$372.5M
Q1 25
$198.0M
$366.9M
Q4 24
$173.9M
$371.5M
Q3 24
$185.4M
$380.0M
Q2 24
$187.6M
$399.9M
Q1 24
$191.9M
$376.4M
Total Assets
INGN
INGN
SWBI
SWBI
Q4 25
$298.6M
$548.6M
Q3 25
$307.0M
$554.6M
Q2 25
$312.0M
$559.6M
Q1 25
$308.4M
$578.9M
Q4 24
$296.2M
$587.4M
Q3 24
$306.2M
$571.3M
Q2 24
$308.9M
$577.4M
Q1 24
$315.6M
$570.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
SWBI
SWBI
Operating Cash FlowLast quarter
$-943.0K
$27.3M
Free Cash FlowOCF − Capex
$-1.9M
$16.3M
FCF MarginFCF / Revenue
-2.8%
13.1%
Capex IntensityCapex / Revenue
1.4%
8.8%
Cash ConversionOCF / Net Profit
14.22×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$21.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
SWBI
SWBI
Q4 25
$-943.0K
$27.3M
Q3 25
$2.2M
$-8.1M
Q2 25
$4.3M
$40.8M
Q1 25
$-16.8M
$-9.8M
Q4 24
$-3.0M
$-7.4M
Q3 24
$7.0M
$-30.8M
Q2 24
$6.7M
$43.7M
Q1 24
$-4.7M
$25.2M
Free Cash Flow
INGN
INGN
SWBI
SWBI
Q4 25
$-1.9M
$16.3M
Q3 25
$1.6M
$-12.4M
Q2 25
$3.7M
$33.5M
Q1 25
$-17.1M
$-16.1M
Q4 24
$-3.3M
$-10.7M
Q3 24
$5.3M
$-35.5M
Q2 24
$6.6M
$38.2M
Q1 24
$-6.1M
$7.0M
FCF Margin
INGN
INGN
SWBI
SWBI
Q4 25
-2.8%
13.1%
Q3 25
2.0%
-14.6%
Q2 25
4.6%
23.8%
Q1 25
-24.9%
-13.9%
Q4 24
-5.0%
-8.3%
Q3 24
7.1%
-40.2%
Q2 24
8.9%
24.0%
Q1 24
-9.6%
5.1%
Capex Intensity
INGN
INGN
SWBI
SWBI
Q4 25
1.4%
8.8%
Q3 25
0.7%
5.0%
Q2 25
0.9%
5.2%
Q1 25
0.4%
5.4%
Q4 24
0.5%
2.5%
Q3 24
2.2%
5.3%
Q2 24
0.1%
3.5%
Q1 24
2.1%
13.2%
Cash Conversion
INGN
INGN
SWBI
SWBI
Q4 25
14.22×
Q3 25
Q2 25
4.73×
Q1 25
-4.68×
Q4 24
-1.63×
Q3 24
Q2 24
1.57×
Q1 24
3.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

SWBI
SWBI

Segment breakdown not available.

Related Comparisons